- US-listed companies
- WEST PHARMACEUTICAL SERVICES INC
- Balance sheet
WEST PHARMACEUTICAL SERVICES INC【WST】Balance sheet
Market cap
$19.8B
P/E ratio
| 2010/12 | 2012/12 | 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Cash and cash equivalents | 110 | 162 | 230 | 255 | 275 | 203 | 236 | 337 | 439 | 616 | 763 | 894 | 854 | 485 |
| Marketable securities, current | - | 12 | 8 | - | - | - | - | - | - | - | - | - | - | - |
| Total cash & short-term investments | 110 | 174 | 238 | 255 | 275 | 203 | 236 | 337 | 439 | 616 | 763 | 894 | 854 | 485 |
| Accounts receivable, net | 126 | 175 | 186 | 179 | 181 | 201 | 253 | 288 | 319 | 385 | 489 | 507 | 512 | 553 |
| Inventories | 147 | 162 | 177 | 182 | 181 | 199 | 215 | 215 | 236 | 321 | 378 | 415 | 435 | 377 |
| Total current assets | 437 | 557 | 651 | 659 | 674 | 642 | 744 | 894 | 1,059 | 1,374 | 1,742 | 1,920 | 1,936 | 1,538 |
| Property, plant and equipment, net | 555 | 669 | 712 | 706 | 721 | 778 | 855 | 822 | 839 | 943 | 1,058 | 1,158 | 1,413 | 1,582 |
| Total non-current assets | 858 | 1,007 | 1,021 | 1,012 | 1,021 | 1,075 | 1,119 | 1,085 | 1,283 | 1,420 | 1,572 | 1,697 | 1,893 | 2,105 |
| Total assets | 1,294 | 1,564 | 1,672 | 1,671 | 1,695 | 1,717 | 1,863 | 1,979 | 2,341 | 2,794 | 3,314 | 3,617 | 3,830 | 3,643 |
| Accounts payable | 63 | 103 | 108 | 103 | 120 | 122 | 138 | 130 | 157 | 213 | 232 | 215 | 242 | 239 |
| Total current liabilities | 170 | 262 | 237 | 253 | 314 | 241 | 280 | 284 | 342 | 503 | 594 | 519 | 672 | 550 |
| Long-term debt, non-current | 358 | 379 | 371 | 310 | 229 | 226 | 197 | 196 | 255 | 253 | 209 | 207 | 73 | 203 |
| Total non-current liabilities | 499 | 573 | 528 | 462 | 357 | 358 | 303 | 299 | 427 | 436 | 384 | 413 | 277 | 411 |
| Total liabilities | 669 | 835 | 765 | 714 | 671 | 599 | 583 | 583 | 768 | 939 | 978 | 932 | 949 | 961 |
| Common stock and paid-in capital | 86 | 88 | 138 | 178 | 226 | 279 | 328 | 301 | 292 | 286 | 268 | 251 | 139 | 41 |
| Retained earnings | 613 | 720 | 805 | 902 | 965 | 1,072 | 1,178 | 1,353 | 1,549 | 1,847 | 2,457 | 2,988 | 3,523 | 3,957 |
| Stockholders' equity | 626 | 729 | 906 | 957 | 1,024 | 1,118 | 1,280 | 1,396 | 1,573 | 1,855 | 2,335 | 2,685 | 2,881 | 2,682 |
| Total debt | 358 | 379 | 371 | 308 | 229 | 226 | 197 | 196 | 257 | 255 | 253 | 207 | 73 | 203 |
| Net debt | 248 | 205 | 134 | 53 | -46 | 23 | -39 | -141 | -182 | -360 | -510 | -688 | -781 | -282 |
| D/E ratio (%) | 57.2 | 52 | 41 | 32.2 | 22.4 | 20.2 | 15.4 | 14 | 16.4 | 13.8 | 10.8 | 7.7 | 2.5 | 7.6 |
| Working capital |